|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0012133,
umls-concept:C0020336,
umls-concept:C0020402,
umls-concept:C0030705,
umls-concept:C0036043,
umls-concept:C0087111,
umls-concept:C0205251,
umls-concept:C0205265,
umls-concept:C0376705,
umls-concept:C0439230,
umls-concept:C0683598,
umls-concept:C1555582,
umls-concept:C1979963,
umls-concept:C2003903
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-1-26
|
|
pubmed:abstractText |
To evaluate the long-term safety and efficacy of the combination of hydroxychloroquine, hydroxyurea and didanosine.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1464-2662
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
13-20
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15670247-Adult,
pubmed-meshheading:15670247-Anti-HIV Agents,
pubmed-meshheading:15670247-CD4 Lymphocyte Count,
pubmed-meshheading:15670247-Didanosine,
pubmed-meshheading:15670247-Drug Resistance, Viral,
pubmed-meshheading:15670247-Drug Therapy, Combination,
pubmed-meshheading:15670247-Female,
pubmed-meshheading:15670247-HIV Infections,
pubmed-meshheading:15670247-HIV-1,
pubmed-meshheading:15670247-Humans,
pubmed-meshheading:15670247-Hydroxychloroquine,
pubmed-meshheading:15670247-Hydroxyurea,
pubmed-meshheading:15670247-Male,
pubmed-meshheading:15670247-Mutation,
pubmed-meshheading:15670247-Treatment Outcome,
pubmed-meshheading:15670247-Viral Load
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV-infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks.
|
|
pubmed:affiliation |
Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore. nick.paton2003@hotmail.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
